Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 0.5916 USD -4.66% Market Closed
Market Cap: 26.4m USD

Wall Street
Price Targets

HBIO Price Targets Summary
Harvard Bioscience Inc

Wall Street analysts forecast HBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HBIO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

Lowest
Price Target
2.02 USD
241% Upside
Average
Price Target
2.04 USD
245% Upside
Highest
Price Target
2.1 USD
255% Upside
Harvard Bioscience Inc Competitors:
Price Targets
CSBR
Champions Oncology Inc
73% Upside
DXRX
Diaceutics PLC
45% Upside
QGEN
Qiagen NV
15% Upside
301333
R&G PharmaStudies Co Ltd
11% Downside
QTRX
Quanterix Corp
7% Downside
OABI
OmniAb Inc
294% Upside
SAILIFE
Sai Life Sciences Ltd
21% Upside
BANB
Bachem Holding AG
15% Upside

Revenue
Forecast

Revenue Estimate
Harvard Bioscience Inc

For the last 13 years the compound annual growth rate for Harvard Bioscience Inc's revenue is -1%. The projected CAGR for the next 2 years is 0%.

-1%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Harvard Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-67%
Average Miss

Net Income
Forecast

Net Income Estimate
Harvard Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HBIO's stock price target?
Price Target
2.04 USD

According to Wall Street analysts, the average 1-year price target for HBIO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

What is Harvard Bioscience Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Harvard Bioscience Inc's revenue is -1%. The projected CAGR for the next 2 years is 0%.

Back to Top